@ARTICLE{
author={Rubovszky Gabor,Kocsis Judit,Boer Katalin,Chilingirova Nataliya,Dank Magdolna,Kahan Zsuzsanna,Kaidarova Dilyara,Kover Erika,Vertkov-Krakovska Bibiana,Mahr Karoly,Mrinakova Bela,Piko Bela,Bozovic-Spasojevic Ivana M,Horvath Zsolt},
year={2023},
title={Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer (vol 28, 1610383, 2022)},
journal={PATHOLOGY & ONCOLOGY RESEARCH},
volume={29},
number={},
pages={-},
document_type={Correction},
} 

@ARTICLE{
author={Rubovszky Gabor,Kocsis Judit,Boer Katalin,Chilingirova Nataliya,Dank Magdolna,Kahan Zsuzsanna,Kaidarova Dilyara,Kover Erika,Vertkov-Krakovska Bibiana,Mahr Karoly,Mrinakova Bela,Piko Bela,Bozovic-Spasojevic Ivana M,Horvath Zsolt},
year={2022},
title={Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer},
journal={PATHOLOGY & ONCOLOGY RESEARCH},
volume={28},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Ciuleanu Tudor E,Nikolic Vladimir,Shmueli E,Vrbanec Damir,Plate Signe,Mrsic-Krmpotic Zrinka,Dank Magdolna,Purkalne Gunta,Brodowicz Thomas,Zielinski Christoph},
year={2011},
title={Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={29},
number={4},
pages={-},
document_type={Meeting Abstract},
}